- Home
- FTRE vs GBAB Comparison
FTRE vs GBAB Comparison
Compare FTRE & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- GBAB
- Stock Information
- Founded
- FTRE 1996
- GBAB 2010
- Country
- FTRE United States
- GBAB United States
- Employees
- FTRE N/A
- GBAB N/A
- Industry
- FTRE Medical Specialities
- GBAB Investment Managers
- Sector
- FTRE Health Care
- GBAB Finance
- Exchange
- FTRE Nasdaq
- GBAB Nasdaq
- Market Cap
- FTRE 469.0M
- GBAB 398.8M
- IPO Year
- FTRE N/A
- GBAB N/A
- Fundamental
- Price
- FTRE $5.28
- GBAB $14.83
- Analyst Decision
- FTRE Hold
- GBAB
- Analyst Count
- FTRE 11
- GBAB 0
- Target Price
- FTRE $17.10
- GBAB N/A
- AVG Volume (30 Days)
- FTRE 3.7M
- GBAB 69.4K
- Earning Date
- FTRE 05-12-2025
- GBAB 01-01-0001
- Dividend Yield
- FTRE N/A
- GBAB 9.18%
- EPS Growth
- FTRE N/A
- GBAB N/A
- EPS
- FTRE N/A
- GBAB N/A
- Revenue
- FTRE $2,685,600,000.00
- GBAB N/A
- Revenue This Year
- FTRE N/A
- GBAB N/A
- Revenue Next Year
- FTRE $1.33
- GBAB N/A
- P/E Ratio
- FTRE N/A
- GBAB N/A
- Revenue Growth
- FTRE N/A
- GBAB N/A
- 52 Week Low
- FTRE $3.97
- GBAB $14.22
- 52 Week High
- FTRE $28.41
- GBAB $17.44
- Technical
- Relative Strength Index (RSI)
- FTRE 53.54
- GBAB 44.44
- Support Level
- FTRE $3.97
- GBAB $14.72
- Resistance Level
- FTRE $4.46
- GBAB $14.97
- Average True Range (ATR)
- FTRE 0.37
- GBAB 0.16
- MACD
- FTRE 0.20
- GBAB 0.01
- Stochastic Oscillator
- FTRE 78.92
- GBAB 61.90
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.